Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

2.3K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.3K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

7.9K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.9K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

791
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
791

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A grading system of dynamic fibrinolysis resistance in sepsis associates with ICU outcomes.

American journal of respiratory and critical care medicine·2026
Same author

Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses.

Viruses·2024
Same author

Protracted fibrinolysis resistance following cardiac surgery with cardiopulmonary bypass: A prospective observational study of clinical associations and patient outcomes.

Acta anaesthesiologica Scandinavica·2024
Same author

Viscoelastometry to Manage Bleeding in Liver Disease.

Cureus·2023
Same author

Point-of-care diagnosis and monitoring of fibrinolysis resistance in the critically ill: results from a feasibility study.

Critical care (London, England)·2023
Same author

Treatment of immune thrombocytopenia in Australian adults: A multicenter retrospective observational study.

Research and practice in thrombosis and haemostasis·2022

Related Experiment Video

Updated: Nov 2, 2025

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.2K

The Current Role of Platelet Function Testing in Clinical Practice.

George A Mason1, David J Rabbolini2,3

  • 1Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia.

Seminars in Thrombosis and Hemostasis
|June 15, 2021
PubMed
Summary
This summary is machine-generated.

Platelet function tests assess bleeding or clotting risks. Understanding these tests helps guide patient management and prevent adverse vascular events.

More Related Videos

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
06:32

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

541
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.0K

Related Experiment Videos

Last Updated: Nov 2, 2025

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.2K
Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
06:32

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

541
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.0K

Area of Science:

  • Hematology
  • Clinical Pathology
  • Cardiology

Background:

  • Platelet dysfunction can lead to bleeding or thrombosis.
  • Vascular interventions increase risks of bleeding and thrombosis.
  • Accurate platelet function testing is crucial for risk assessment.

Purpose of the Study:

  • To review traditional and contemporary platelet function tests.
  • To evaluate their role in clinical practice.
  • To guide perioperative management strategies.

Main Methods:

  • Critical appraisal of existing literature.
  • Analysis of analytical strengths and limitations of tests.
  • Focus on clinical application and extrapolation of results.

Main Results:

  • A wide range of platelet function tests are available.
  • Knowledge of test limitations is essential for accurate interpretation.
  • Tests inform bleeding/thrombosis risk and management.

Conclusions:

  • Platelet function testing is vital for managing bleeding and thrombosis risks.
  • Understanding test performance is key to successful clinical application.
  • This review provides insights into optimizing test utilization.